SARS-CoV-2 / COVID-19
- Outpatient treatment is for high-risk disease
- Nirmatrelvir/ritonavir preferred when usable
- Remdesivir is an effective early IV alternative
- Start antiviral treatment early
- Check ritonavir DDIs before prescribing
- Steroid is for oxygen need—not mild disease
- Immunomodulators are for severe inflammation
Use at a glance
- Outpatient treatment is for high-risk disease
Treatment options
- Remdesivir is an effective early IV alternative
- Start antiviral treatment early
Choosing treatment
- Nirmatrelvir/ritonavir preferred when usable
- Steroid is for oxygen need—not mild disease
- Immunomodulators are for severe inflammation
Practical pearls
- Check ritonavir DDIs before prescribing
Self-check
- What should be started in SARS-CoV-2 / COVID-19?
antiviral treatment early.
- What should be checked in SARS-CoV-2 / COVID-19?
ritonavir DDIs before prescribing.
Drugs used for this (3)
All clinical uses · Open the interactive console ↗
